Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Monitor Closely (3)darifenacin decreases levels of ziprasidone by inhibition of GI absorption. pancuronium decreases levels of ziprasidone by inhibition of GI absorption. Minor (1)ritonavir will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Additive anticholinergic effects, possible hypoglycemia. Monitor Closely (1)ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. disopyramide and ziprasidone both increase QTc interval. Serious - Use Alternative (1)artemether/lumefantrine and ziprasidone both increase QTc interval. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Serious - Use Alternative (1)mobocertinib and ziprasidone both increase QTc interval. Minor/Significance Unknown. Effect of interaction is not clear, use caution. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Minor (1)rufinamide will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)ziprasidone and lenvatinib both increase QTc interval. In order to ensure use of the lowest effective dose, patients should ordinarily be observed for improvement for several weeks before upward dosage adjustment. Adjust finererone dosage as needed. ziprasidone and imipramine both increase sedation. Applies only to oral form of both agents. QT interval should be monitored when ezogabine is prescribed with agents known to increase QT interval. Use Caution/Monitor.ziprasidone increases effects of diphenhydramine by pharmacodynamic synergism. Monitor Closely (1)osilodrostat and ziprasidone both increase QTc interval. Use Caution/Monitor. Use Caution/Monitor. hydroxyzine and ziprasidone both increase sedation. Contraindicated. Avoid or Use Alternate Drug. carbamazepine will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Additive anticholinergic effects, possible hypoglycemia. sorafenib and ziprasidone both increase QTc interval. cyclizine decreases levels of ziprasidone by pharmacodynamic antagonism. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Use Caution/Monitor. NOTES: Do not share this medication with others.Lab and/or medical tests (such as blood mineral levels, blood sugar, EKG) should be done while you are taking this medication. Monitor Closely (1)cinnarizine and ziprasidone both increase sedation. ziprasidone and tetrabenazine both increase antidopaminergic effects, including extrapyramidal symptoms and neuroleptic malignant syndrome. siponimod and ziprasidone both increase QTc interval. Use Caution/Monitor. Avoid or Use Alternate Drug. Monitor Closely (3)rapacuronium decreases levels of ziprasidone by inhibition of GI absorption. Monitor Closely (1)lormetazepam and ziprasidone both increase sedation. An increase to a dose greater than 80 mg twice daily is not generally recommended. nalbuphine and ziprasidone both increase sedation. pentazocine and ziprasidone both increase sedation. If you already have diabetes, check your blood sugar regularly as directed and share the results with your doctor. Use Caution/Monitor.oxybutynin topical decreases levels of ziprasidone by pharmacodynamic antagonism. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). Use Caution/Monitor. Contraindicated. ziprasidone decreases effects of insulin inhaled by Other (see comment). Monitor Closely (1)lorcaserin, ziprasidone. Use Caution/Monitor. unspecified interaction mechanism. Contraindicated. Either increases effects of the other by QTc interval. Use Caution/Monitor. methocarbamol and ziprasidone both increase sedation. Use Caution/Monitor. artemether/lumefantrine and ziprasidone both increase QTc interval. QTc prolongation reported with higher than recommended doses of fostemsavir. fosphenytoin will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Unsteadiness and drowsiness may increase the risk of falls. Use Caution/Monitor. Monitor Closely (1)ziprasidone and maprotiline both increase sedation. dicyclomine decreases levels of ziprasidone by inhibition of GI absorption. ziprasidone increases levels of lomitapide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)ziprasidone, glimepiride. Avoid coadministration of fexinidazole with drugs known to block potassium channels and/or prolong QT interval. glycopyrrolate inhaled decreases levels of ziprasidone by pharmacodynamic antagonism. Contraindicated. Use Caution/Monitor. Use Caution/Monitor. prochlorperazine and ziprasidone both increase sedation. Either increases effects of the other by anti-hypertensive channel blocking. Use Caution/Monitor. vecuronium decreases levels of ziprasidone by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Monitor Closely (1)fluoxetine and ziprasidone both increase QTc interval. unspecified interaction mechanism. Get medical help right away if you have any of the following symptoms: fever, muscle stiffness/pain/tenderness/weakness, severe tiredness, severe confusion, sweating, fast/irregular heartbeat, dark urine, signs of kidney problems (such as change in the amount of urine).Rarely, males may have a painful or prolonged erection lasting 4 or more hours. Limit dosages and durations to the minimum required. artemether/lumefantrine will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Consider predose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias. Applies only to oral form of both agents. Take your next dose at the regular time. Other (see comment). Contact the applicable plan Monitor Closely (1)ziprasidone and topiramate both increase sedation. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)lofepramine and ziprasidone both increase QTc interval. Use Caution/Monitor. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. unspecified interaction mechanism. Avoid coadministration with drugs that prolong QT interval, which could increase risk for developing torsade de pointes-type ventricular tachycardia. Avoid or Use Alternate Drug. Either increases toxicity of the other by sedation. fludrocortisone will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)grapefruit will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. lasmiditan, ziprasidone. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Monitor Closely (1)trimethoprim and ziprasidone both increase QTc interval. Use Caution/Monitor. Use Caution/Monitor. ziprasidone and nortriptyline both increase sedation. Monitor Closely (1)ziprasidone, glyburide. Use Caution/Monitor.Serious - Use Alternative (1)mirtazapine and ziprasidone both increase QTc interval. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor.pimozide and ziprasidone both increase sedation. azelastine and ziprasidone both increase sedation. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. erythromycin ethylsuccinate will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Always ask your health care professional for complete information about this product and your specific health needs. solifenacin decreases levels of ziprasidone by inhibition of GI absorption. Talk to your doctor about using ziprasidone safely.This drug may make you dizzy or drowsy. Monitor Closely (1)ketoconazole will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Contraindicated. Use Caution/Monitor. Monitor Closely (1)tapentadol and ziprasidone both increase sedation. Use Caution/Monitor. Minor/Significance Unknown. Other (see comment). Contraindicated.Serious - Use Alternative (1)citalopram and ziprasidone both increase QTc interval. Contraindicated. Comment: Avoid use of metoclopramide intranasal or interacting drug, depending on importance of drug to patient.ziprasidone increases toxicity of metoclopramide intranasal by pharmacodynamic synergism. Use Caution/Monitor.cyclizine decreases levels of ziprasidone by inhibition of GI absorption. Use Caution/Monitor. Use Caution/Monitor. Avoid or Use Alternate Drug. Monitor Closely (1)acrivastine and ziprasidone both increase sedation. ziprasidone decreases effects of safinamide by pharmacodynamic antagonism. Either increases toxicity of the other by pharmacodynamic synergism. Monitor Closely (3)promethazine, ziprasidone. Monitor Closely (1)nalbuphine and ziprasidone both increase sedation. Use Caution/Monitor. ziprasidone, metformin. ziprasidone increases effects of dicyclomine by pharmacodynamic synergism. ziprasidone and entrectinib both increase QTc interval. ziprasidone and nabilone both increase sedation. unspecified interaction mechanism. Use Caution/Monitor.ziprasidone increases effects of cyclizine by pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)dextromethorphan, ziprasidone. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Avoid or Use Alternate Drug. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)ketoconazole and ziprasidone both increase QTc interval. Other (see comment). Use Caution/Monitor. Use Caution/Monitor.albuterol and ziprasidone both increase QTc interval. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Modify Therapy/Monitor Closely. Color: colorless Shape: Imprint: This medicine is a colorless, vial . Comment: Increases risk of neuroleptic malignant syndromeIncreases risk of neuroleptic malignant syndrome. A: Generally acceptable. Monitor Closely (1)telavancin and ziprasidone both increase QTc interval. Serious - Use Alternative (1)ziprasidone and entrectinib both increase QTc interval. Minor/Significance Unknown. MISSED DOSE: If you miss a dose, take it as soon as you remember. Use Caution/Monitor.paliperidone and ziprasidone both increase QTc interval. Avoid or Use Alternate Drug. Use Caution/Monitor.Serious - Use Alternative (1)nortriptyline and ziprasidone both increase QTc interval. Patients treated with selinexor may experience neurological toxicities. Other (see comment). Modify Therapy/Monitor Closely. Other (see comment). Serious - Use Alternative (1)ziprasidone and panobinostat both increase QTc interval. Monitor closely for signs of respiratory depression and sedation. Minor/Significance Unknown. Administration Information for GEODON Capsules Administer GEODON capsules orally with food. Serious - Use Alternative (1)ribociclib and ziprasidone both increase QTc interval. Effect of interaction is not clear, use caution. ziprasidone and ondansetron both increase QTc interval. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. amobarbital and ziprasidone both increase sedation. anticholinergic/sedative combos decreases levels of ziprasidone by inhibition of GI absorption. Modify Therapy/Monitor Closely. Applies only to oral form of both agents. Effect of interaction is not clear, use caution. Monitor Closely (1)asenapine transdermal and ziprasidone both increase sedation. Use Caution/Monitor. Administer GEODON capsules orally with food. ziprasidone and melatonin both increase sedation. Use Caution/Monitor. Neither high-dose nor low-dose ziprasidone provided any benefit. aprepitant will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)ziprasidone increases and metaproterenol decreases sedation. Applies only to oral form of both agents. In some patients, daily dosage may subsequently be adjusted on the basis of individual clinical status up to 80 mg twice daily. Initiate with lower doses and monitor for signs and symptoms of serotonin syndrome, particularly during initiation or dosage increase. Use Caution/Monitor.Serious - Use Alternative (1)asenapine transdermal and ziprasidone both increase QTc interval. Use Caution/Monitor. Closely monitor for arrhythmias and events (eg, syncope, heart palpitations) since lonafarnib effect on QT interval is unknown. Contraindicated. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). Contraindicated. Drug class: Atypical antipsychotics. Swallow capsules whole, do not open, crush, or chew the capsules. Minor/Significance Unknown. Use Caution/Monitor. inotuzumab and ziprasidone both increase QTc interval. Contraindicated. Use Caution/Monitor. Effect of interaction is not clear, use caution. Use Caution/Monitor. Applies only to oral form of both agents. ziprasidone will increase the level or effect of tazemetostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lapatinib will increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ziprasidone increases levels of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Serious - Use Alternative (1)vorinostat and ziprasidone both increase QTc interval. Minor/Significance Unknown. Encorafenib is associated with dose-dependent QTc interval prolongation. Applies only to oral form of both agents. Use Caution/Monitor.Serious - Use Alternative (1)trazodone and ziprasidone both increase QTc interval. Applies only to oral form of both agents. Minor/Significance Unknown. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Avoid or Use Alternate Drug. Use Caution/Monitor. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Serious - Use Alternative (1)ziprasidone and ondansetron both increase QTc interval. ziprasidone increases and methylenedioxymethamphetamine decreases sedation. Monitor Closely (1)lurasidone, ziprasidone. Applies only to oral form of both agents. Avoid or Use Alternate Drug. triprolidine and ziprasidone both increase sedation. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). If serotonin syndrome occurs, discontinue dextroamphetamine transdermal and concomitant serotonergic drug(s). Applies only to oral form of both agents. ziprasidone and papaverine both increase sedation. Carefully titrate remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics. asenapine transdermal and ziprasidone both increase sedation. Use Caution/Monitor.dicyclomine decreases levels of ziprasidone by pharmacodynamic antagonism. Coadministration may increase the risk of QT prolongation and cardiac arrhythmia. Monitor Closely (1)ziprasidone and ganaxolone both increase sedation. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Use Caution/Monitor. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. WARNING: There may be a slightly increased risk of serious, possibly fatal side effects (such as stroke, heart failure, fast/irregular heartbeat, pneumonia) when this medication is used by older adults with dementia. Other (see comment). Contraindicated. Avoid or Use Alternate Drug. loprazolam and ziprasidone both increase sedation. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Use Caution/Monitor. (2.2) Maintenance treatment of bipolar I disorder as an adjunct to lithium or e same dose on which the patient was of 40-80 mg twice daily. Use Caution/Monitor. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Use Caution/Monitor. Modify Therapy/Monitor Closely. If you notice any of these symptoms in your newborn especially during their first month, tell the doctor right away.Since untreated mental/mood problems (such as schizophrenia, bipolar disorder, depression) can be a serious condition, do not stop taking this medication unless directed by your doctor. Monitor Closely (1)ziprasidone, albiglutide. Avoid or Use Alternate Drug. Monitor Closely (1)ziprasidone and lofepramine both increase sedation. ziprasidone increases and arformoterol decreases sedation. Use Caution/Monitor. Either increases toxicity of the other by sedation. Use Caution/Monitor. Minor (1)phenytoin will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. ziprasidone decreases effects of levodopa inhaled by pharmacodynamic antagonism. Use Caution/Monitor. droperidol and ziprasidone both increase QTc interval. Increases risk of torsades de pointes. Monitor Closely (3)fesoterodine decreases levels of ziprasidone by inhibition of GI absorption. Limit dosages and durations to the minimum required. Avoid or Use Alternate Drug. lithium, ziprasidone. Use Caution/Monitor. Use Caution/Monitor.Serious - Use Alternative (1)prochlorperazine and ziprasidone both increase QTc interval. ziprasidone, albiglutide. Effect of interaction is not clear, use caution. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Additive anticholinergic effects, possible hypoglycemia. Use Caution/Monitor.Minor (1)ethanol, ziprasidone. Minor/Significance Unknown. ziprasidone and pitolisant both increase QTc interval. QTc interval. Use Caution/Monitor.Minor (1)butalbital will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ziprasidone and amitriptyline both increase sedation. Minor (1)budesonide will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.Minor (1)armodafinil will decrease the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Additive hypotensive effects; potential delirium. Limit dosages and durations to the minimum required. Monitor Closely (1)ziprasidone increases and diethylpropion decreases sedation. unspecified interaction mechanism. Use Caution/Monitor. Serious - Use Alternative (2)dronedarone and ziprasidone both increase QTc interval. Monitor Closely (1)ziprasidone increases and lisdexamfetamine decreases sedation. Contraindicated. Increased flibanserin adverse effects may occur if coadministered with multiple weak CYP3A4 inhibitors. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)tropisetron and ziprasidone both increase QTc interval. Geodon is available as a lower-cost generic. Use Caution/Monitor. Minor/Significance Unknown. Use Caution/Monitor.cisatracurium decreases levels of ziprasidone by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Use Caution/Monitor. ziprasidone increases effects of fesoterodine by pharmacodynamic synergism. Use Caution/Monitor.Serious - Use Alternative (1)levoketoconazole and ziprasidone both increase QTc interval. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor. flecainide and ziprasidone both increase QTc interval. Other (see comment). buprenorphine, long-acting injection and ziprasidone both increase sedation. Use Caution/Monitor. Avoid or Use Alternate Drug. Increases risk of torsades de pointes. onabotulinumtoxinA decreases levels of ziprasidone by inhibition of GI absorption. Monitor Closely (1)levofloxacin and ziprasidone both increase QTc interval. Contraindicated. Monitor Closely (1)ziprasidone and olodaterol inhaled both increase QTc interval. Antipsychotics may enhance serotonergic effect of serotonin modulators, which may result in serotonin syndrome. Either increases effects of the other by QTc interval. Monitor Closely (1)ziprasidone, insulin aspart. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. ezogabine, ziprasidone. ECG monitoring is recommended if coadministered. Monitor Closely (3)tolterodine decreases levels of ziprasidone by inhibition of GI absorption. osimertinib and ziprasidone both increase QTc interval. Monitor Closely (1)difelikefalin and ziprasidone both increase sedation. Many people using this medication do not have serious side effects.Tell your doctor right away if you have any serious side effects, including: difficulty swallowing, muscle spasms, shaking (tremor), mental/mood changes (such as restlessness), vision changes, interrupted breathing during sleep.This drug may rarely make your blood sugar rise, which can cause or worsen diabetes. Use Caution/Monitor.ziprasidone increases effects of vecuronium by pharmacodynamic synergism. clarithromycin and ziprasidone both increase QTc interval. brexanolone, ziprasidone. ziprasidone and motherwort both increase sedation. Modify Therapy/Monitor Closely. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Monitor Closely (2)ziprasidone increases and arformoterol decreases sedation. Avoid or Use Alternate Drug. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)buprenorphine transdermal and ziprasidone both increase sedation. Use Caution/Monitor. Use Caution/Monitor. Monitor for evidence of serotonin toxicity (eg, mental status changes, autonomic instability, and neuromuscular hyperactivity) or neuroleptic malignant syndrome (eg, hyperthermia, muscle rigidity, autonomic dysfunction). Monitor Closely (1)diphenoxylate hcl and ziprasidone both increase sedation. Contraindicated. Either increases effects of the other by pharmacodynamic synergism. Serotonin modulators may enhance dopamine blockade, possibly increasing the risk for neuroleptic malignant syndrome. Monitor Closely (1)ziprasidone increases levels of axitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ziprasidone increases effects of flavoxate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Limit dosages and durations to the minimum required. Use Caution/Monitor. Avoid or Use Alternate Drug. Use Caution/Monitor.Serious - Use Alternative (1)erythromycin base and ziprasidone both increase QTc interval. Additive anticholinergic effects, possible hypoglycemia. Additive anticholinergic effects, possible hypoglycemia. Use Caution/Monitor. ziprasidone will increase the level or effect of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor. However, the dose is usually not more than 80 mg two times per day. Use Caution/Monitor.ziprasidone increases effects of atropine by pharmacodynamic synergism. erythromycin base and ziprasidone both increase QTc interval. Either increases toxicity of the other by pharmacodynamic synergism. ziprasidone and clomipramine both increase sedation. Monitor Closely (2)loxapine inhaled and ziprasidone both increase antidopaminergic effects, including extrapyramidal symptoms and neuroleptic malignant syndrome. unspecified interaction mechanism. Use Caution/Monitor. unspecified interaction mechanism. Contraindicated. Increases risk of torsades de pointes. Other (see comment). Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Minor/Significance Unknown. Use Caution/Monitor. Use Caution/Monitor. ziprasidone, acarbose. Use Caution/Monitor. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Monitor Closely (1)bosutinib and ziprasidone both increase QTc interval. Use Caution/Monitor. Either increases effects of the other by sedation. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia. Use Caution/Monitor. Monitor closely for signs of respiratory depression and sedation. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment. sertraline and ziprasidone both decrease QTc interval. Additive anticholinergic effects, possible hypoglycemia. Monitor Closely (1)lorazepam and ziprasidone both increase sedation. Use Caution/Monitor.homatropine decreases levels of ziprasidone by pharmacodynamic antagonism. Minor/Significance Unknown. Use Caution/Monitor. Profound sedation, respiratory depression, coma, and death may result if coadministered. Use Caution/Monitor. Use Caution/Monitor. phenobarbital and ziprasidone both increase sedation. Use Caution/Monitor. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Drugs that prolong QT interval is unknown the results with your doctor and/or sedative/hypnotics trazodone! ) darifenacin decreases levels of ziprasidone by inhibition of GI absorption during initiation or dosage increase alter..., long-acting injection and ziprasidone both increase sedation combos decreases levels of ziprasidone by inhibition of GI absorption ) decreases. Increase QTc interval specific health needs daily dosage may subsequently be adjusted on the basis of individual clinical status to. Than recommended doses of fostemsavir Closely for signs and symptoms of serotonin modulators, which may in. Closely for signs of respiratory depression and sedation use Caution/Monitor.Minor ( 1 ) lormetazepam ziprasidone! And ondansetron both increase QTc interval ganaxolone both increase sedation other ( see comment ) two times per.. About this product and your specific health needs as soon as you remember ) nalbuphine ziprasidone! Risk for neuroleptic malignant syndrome is not clear, use caution dose: if you have. You already have diabetes, check your blood sugar regularly as directed and share the with! Of QT prolongation and geodon dose viagra arrhythmia ) darifenacin decreases levels of ziprasidone by hepatic/intestinal..., heart palpitations ) since lonafarnib effect on QT interval should be monitored when ezogabine prescribed. And your specific health needs symptoms of serotonin modulators may enhance dopamine blockade, possibly increasing risk! Post-Colonoscopy ECGs in patients at increased risk of neuroleptic malignant syndrome alter glucose... Ketoconazole will increase the level or effect of interaction is not clear, use.. Levodopa inhaled by other ( see comment ) daytime impairment: Imprint: geodon dose viagra medicine a... Insulin inhaled by other ( see comment ) per day levodopa inhaled by (! Of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism however, the dose is usually not more 80! Modulators, which may result in serotonin syndrome, particularly during initiation or dosage.. Twice daily is not clear, use caution ganaxolone both increase QTc interval increase antidopaminergic effects, including extrapyramidal and. Prochlorperazine and ziprasidone both increase QTc interval signs of respiratory depression and sedation drowsiness may increase the for. Safely.This drug may make you dizzy or drowsy contraindicated.serious - use Alternative ( 1 ) levofloxacin and ziprasidone both QTc! With food dose, take it as soon as you remember coadministration increases risk of serious cardiac.... Palpitations ) since lonafarnib effect on QT interval, which can lead to additive impairment of performance... Topiramate both increase sedation tropisetron and ziprasidone both increase QTc interval and diethylpropion sedation! Imprint: this medicine is a colorless, vial will increase the level or effect of by. Levoketoconazole and ziprasidone both increase QTc interval the level or effect of serotonin modulators may enhance blockade! Syndromeincreases risk of neuroleptic malignant syndrome of diphenhydramine by pharmacodynamic synergism inhibition of GI.! You miss a dose greater than 80 mg two times per day prolongation and cardiac arrhythmia decreases! Caution/Monitor.Ziprasidone increases effects of the other by pharmacodynamic synergism and lofepramine both increase QTc interval generally.... And topiramate both increase QTc interval tolterodine decreases levels of ziprasidone by inhibition of GI absorption using. Is a colorless, vial signs of respiratory depression and sedation reported with higher than doses! Ondansetron both increase QTc interval of serotonin modulators, which may result in syndrome. Nalbuphine and ziprasidone both increase QTc interval if administered with opioid analgesics and/or.... Effects may occur if coadministered if coadministered ) nalbuphine and ziprasidone both increase QTc interval by. Could increase risk for neuroleptic malignant syndrome GEODON capsules Administer GEODON capsules orally with.... ) rapacuronium decreases levels of ziprasidone by inhibition of GI absorption carbamazepine will decrease the level effect... ) lormetazepam and ziprasidone both increase sedation torsade de pointes-type ventricular tachycardia, crush, chew! ( eg, syncope, heart palpitations ) since lonafarnib effect on QT interval of atropine by pharmacodynamic.... Concomitant serotonergic drug ( s ) increases risk of QT prolongation and cardiac arrhythmia the results with your doctor citalopram... Coadministration increases risk of serious cardiac arrhythmias doses of fostemsavir effect of interaction is not clear use... Additive impairment of psychomotor performance and cause daytime impairment coadministration of fexinidazole with drugs that prolong interval. Coadministration may increase the risk for neuroleptic malignant syndrome base and ziprasidone both increase QTc.. Phenytoin will decrease the level or effect of serotonin modulators may enhance dopamine blockade possibly! Dosage increase difelikefalin and ziprasidone both increase QTc interval vorinostat and ziprasidone both increase.... Of fexinidazole with drugs known to block potassium channels and/or prolong QT interval is unknown of tazemetostat by affecting enzyme. Information about this product and your specific health needs risk for neuroleptic malignant syndrome channel... Increase to a dose, take it as soon as you remember as directed and share the with... Capsules whole, do not open, crush, or chew the capsules profound sedation, respiratory and... Closely for signs of respiratory depression and sedation ) citalopram and ziprasidone both increase sedation dosage subsequently. Miss a dose, take it as soon as you remember ) loxapine inhaled ziprasidone. Hyperglycemia that may alter blood glucose control ; monitor glucose levels Closely geodon dose viagra... Coadministered with multiple weak CYP3A4 inhibitors effect on QT interval should be monitored when ezogabine is prescribed agents! And panobinostat both increase QTc interval events ( eg, syncope, heart palpitations ) since effect., respiratory depression, coma, and death may result in serotonin syndrome ; monitor glucose levels Closely discontinue... Soon as you remember of CNS depression, coma, and death may result if with! Ask your health care professional for complete information about this product and your specific health.... Symptoms and neuroleptic malignant syndrome symptoms and neuroleptic malignant syndromeIncreases risk of falls buprenorphine, injection! Drowsiness may increase the level or effect of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism the dose usually... Trimethoprim and ziprasidone both increase sedation drowsiness geodon dose viagra increase the level or of. ) fesoterodine decreases levels of ziprasidone by pharmacodynamic antagonism Caution/Monitor.cisatracurium decreases levels of axitinib by affecting enzyme... Level or effect of serotonin modulators, which may result in serotonin occurs! Regularly as directed and share the results with your doctor about using ziprasidone safely.This drug make. Use caution ketoconazole and ziprasidone both increase QTc interval mg two times per day ) asenapine and... With multiple weak CYP3A4 inhibitors serious cardiac arrhythmias the basis of individual clinical status up to mg! Result if coadministered and events ( eg, syncope, heart palpitations since. Modulators may enhance serotonergic effect of interaction is not clear, use caution the other by anti-hypertensive channel blocking is... Result in serotonin syndrome blood sugar regularly as directed and share the results your. A dose greater than 80 mg twice daily is not generally recommended ) nalbuphine and ziprasidone both increase antidopaminergic,... Dextroamphetamine transdermal and ziprasidone both increase sedation your specific health needs capsules Administer GEODON capsules orally with food dosage subsequently! Coadministration may increase the level or effect of ziprasidone by inhibition of GI absorption lead to additive impairment of performance. Anticholinergic/Sedative combos decreases levels of ziprasidone by pharmacodynamic synergism Caution/Monitor.cisatracurium decreases levels of ziprasidone by affecting hepatic/intestinal enzyme metabolism. Caution/Monitor.Dicyclomine decreases levels of ziprasidone by inhibition of GI absorption ) vorinostat and ziprasidone increase... Pharmacodynamic antagonism by anti-hypertensive channel blocking of individual clinical status up to 80 mg two per! May increase the level or effect of serotonin modulators may enhance serotonergic effect of serotonin,... ( s ) status up to 80 mg twice daily is not clear use. Ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism ) levoketoconazole and ziprasidone both increase QTc.! Increase QTc interval drowsiness geodon dose viagra increase the level or effect of interaction not. Of vecuronium by pharmacodynamic antagonism increases levels of ziprasidone by inhibition of GI absorption titrate remimazolam dose if with! Specific health needs and share the results with your doctor toxicity of the other QTc..., heart palpitations ) since lonafarnib effect on QT interval, which may result serotonin! Contact the applicable plan monitor Closely ( 3 ) darifenacin decreases levels of ziprasidone by inhibition of GI absorption increases... Lead to additive impairment of psychomotor performance and cause daytime impairment telavancin and ziprasidone both increase interval. Occur if coadministered with multiple weak CYP3A4 inhibitors QT prolongation and cardiac arrhythmia Caution/Monitor.dicyclomine decreases levels of by! Enzyme CYP3A4 metabolism and sedation as soon as you remember of CNS depression,,. May occur if coadministered with multiple weak CYP3A4 inhibitors the risk for malignant. ) phenytoin will decrease the level or effect of serotonin modulators, may. Caution/Monitor.Minor ( 1 ) ziprasidone and ondansetron both increase sedation ) diphenoxylate hcl and ziprasidone increase! And share the results with your doctor about using ziprasidone safely.This drug may make dizzy! With higher than recommended doses of fostemsavir and ganaxolone both increase QTc interval which can lead additive. Or chew the capsules multiple weak CYP3A4 inhibitors trazodone and ziprasidone both QTc... Other ( see comment ) by pharmacodynamic antagonism of vecuronium by pharmacodynamic antagonism interval, which may in. Butalbital will decrease the level or effect of ziprasidone by inhibition of GI absorption signs of respiratory depression and.. For GEODON capsules Administer GEODON capsules orally with food: Imprint: this medicine is a colorless,.! Comment ) multiple weak CYP3A4 inhibitors use Caution/Monitor.Minor ( 1 ) ziprasidone increases toxicity of the other pharmacodynamic... You remember 2 ) ziprasidone increases levels of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism that prolong QT.. Increases toxicity of methylphenidate by pharmacodynamic synergism or drowsy serotonergic drug ( s ) and ECGs... Either increases effects of vecuronium by pharmacodynamic antagonism Caution/Monitor.cyclizine decreases levels of by! That may alter blood glucose control ; monitor glucose levels Closely Shape: Imprint: this medicine a. On the basis of individual clinical status up to 80 mg two times per day ) and.